Strong growth rates expected to drive Abbott India's outperformance

New launches, power brands, digital initiatives to keep it ahead of peers

Since its August lows, the Abbott India stock has been on an upswing gaining about 21 per cent on steady June quarter results, brokerage upgrades and expectations of double digit growth going ahead. The momentum for the stock, which hit its all-time high on Tuesday, is expected to continue given the robust sales posted in August.

For the three months ended August, the company outperformed the pharma market with a growth of 22 per cent as compared to 15 per cent growth for the broader market. Barring the vitamins, minerals and nutrition segment which saw a drop in sales, other